| License: Creative Commons Attribution Non-commercial 4.0 PDF - Published Version Early View (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-493382
- DOI to cite this document:
- 10.5283/epub.49338
This publication is part of the DEAL contract with Wiley.
Abstract
Background Plateletpheresis using a leukocyte reduction system (LRS) traps donor WBCs in the LRS chamber, which may lead to lymphopenia, especially in frequent plateletpheresis donors. It seems plausible that this might cause adverse effects. However, current knowledge about potential confounders and donor health impacts is incomplete. Donors and methods Recent platelet donors and donations ...
Owner only: item control page